학술논문
REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal bevacizumab to treat symptomatic ascites in patients with chemotherapy-resistant, epithelial ovarian cancer
Document Type
Article
Author
Source
In Gynecologic Oncology May 2021 161(2):374-381
Subject
Language
ISSN
0090-8258